资讯

Le Lézard7 小时
U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion ...
RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device, ...
U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion ...
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared ...